Welcome to our dedicated page for Arcadia Biosciences news (Ticker: RKDA), a resource for investors and traders seeking the latest updates and insights on Arcadia Biosciences stock.
Arcadia Biosciences, Inc. (NASDAQ: RKDA) is a pioneering company in the field of agricultural biotechnology, focused on developing and marketing high-value food ingredients and nutritional oils. The company’s mission is to meet the growing consumer demand for healthier dietary options through its innovative product offerings.
Among Arcadia’s standout products are its GoodWheat™ branded ingredients, which provide significant health benefits and allow consumer packaged goods companies to differentiate their brands in a competitive marketplace. Additionally, Arcadia is committed to enhancing agricultural productivity and sustainability through its portfolio of agricultural traits. These traits are designed to help farmers around the world increase crop yields and reduce the environmental impact of farming practices.
The company is engaged in science-based approaches to crop improvement, with a focus on wheat, soy, and hemp. These efforts aim not only to improve the performance of these crops in the field but also to enhance their value in food, health, and wellness products, as well as their industrial applications.
Arcadia’s consumer brands cater to a range of markets, including food, beverage, and body care. Some notable brands include GoodWheat™ high-fiber pasta and Zola coconut water. These products highlight the company’s dedication to providing nutritious and beneficial options to consumers.
Recent achievements and ongoing projects reflect Arcadia’s commitment to innovation and sustainability. By leveraging advanced agricultural biotechnology, the company continues to contribute to a healthier future while supporting global agricultural productivity.
For more detailed information and the latest updates, visit their official website at www.arcadiabio.com.
Arcadia Biosciences (Nasdaq: RKDA) will release its financial and business results for Q2 and the first half of 2021 post-market on August 16, 2021. A conference call is scheduled for 4:30 p.m. Eastern time to discuss these results and strategic achievements. Interested parties can join via U.S. Toll-Free Dial-In at +1-844-243-4690 or International Dial-In at +1-225-283-0138. The call will also be available via live webcast on Arcadia's investor website.
Arcadia Biosciences (Nasdaq: RKDA) has appointed Laura Pitlik as its new chief marketing officer to enhance its consumer goods platforms after key acquisitions. Pitlik, an experienced strategist in consumer packaged goods, will manage brand development and omnichannel marketing for Arcadia's health and wellness portfolio, including brands like GoodWheat and Zola. CEO Matt Plavan highlights this strategic move as a way to position the company for growth in the plant-based food sector, leveraging its innovations in nutrition.
Arcadia Biosciences (Nasdaq: RKDA) reported strong first-quarter financial results for 2021, with revenues increasing by 168% to $828,000, driven by GoodWheat and GLA product sales. The company acquired assets from Lief Holdings and Live Zola, contributing $6 million in annual revenue and expanding its distribution network. However, net income decreased to $2.1 million, down 19% from the previous year, mainly due to non-cash income fluctuations. Operating expenses remained stable at $6.2 million.
On May 17, 2021, Arcadia Biosciences (Nasdaq: RKDA) announced the acquisition of assets from Lief Holdings, LLC and Live Zola, LLC. The deal, valued at $4 million in cash plus 827,400 shares, includes prominent CBD brands such as Soul Spring and Saavy Naturals. This acquisition aims to enhance Arcadia's consumer goods strategy in the CBD market and access distribution channels in over 5,000 stores. With expected annual revenues of $6 million from the acquired brands, Arcadia anticipates revenue growth and operational synergies.
Arcadia Biosciences (Nasdaq: RKDA) will announce its first-quarter financial results on May 17, 2021, after market close. A conference call is scheduled for 4:30 p.m. Eastern time to discuss the results and key strategic achievements for the year. Interested participants can join via U.S. Toll-Free or International Dial-In numbers. The conference call will also be available as a live webcast on the Investors section of Arcadia's website. This session provides an opportunity for investors to gain insights into the company’s performance and future outlook.
Arcadia Biosciences (Nasdaq: RKDA) appointed Belinda Yao as vice president of operations on May 10, 2021. Yao will oversee the supply chain strategy for product manufacturing and production. With over 20 years in management, she brings experience from Zola and The Dannon Company. CEO Matt Plavan stated that Yao's expertise will help build an agile supply chain infrastructure to support the launch of new health and nutrition products. The company focuses on enhancing crop quality and nutritional value through its GoodWheat and GoodHemp brands.
Arcadia Biosciences (Nasdaq: RKDA) has announced that three of its GoodHemp™ seed varieties have received approval from Health Canada, facilitating their sale in Canada. This approval follows certification from the Association of Official Seed Certifying Agencies (AOSCA) and enables Canadian growers to access these high-quality seeds for the 2021 planting season. The approved varieties include Umpqua, Rogue, and Santiam, known for their CBD-dominance and high yield potential. Arcadia has already shipped the first seed order to Tritium 3H, its distribution partner in Canada.
Arcadia Biosciences (Nasdaq: RKDA) announced the acquisition of Agrasys S.A., a Barcelona-based food ingredients company. The deal includes all physical and intellectual property assets of Agrasys, enabling Arcadia to commercialize Tritordeum, a nutritious cereal grain developed by IAS-CSIC. Tritordeum is rich in fiber, protein, and lutein, and is suitable for various foods. Agrasys has already commercialized Tritordeum in 10 countries, including a recent launch with Albert Heijn in Europe. Arcadia aims to expand Tritordeum's market in North America and leverage Agrasys' network for its GoodWheat products.
Arcadia Biosciences, Inc. (RKDA) reported record revenues of $8 million for 2020, up 587% from 2019, driven by significant licensing revenue from Bioceres. The company achieved a net income of $10 million in Q4, compared to a loss in the same quarter the previous year. Arcadia expanded its GoodWheat product line and formed partnerships to enhance its market outreach, including a venture with Three Farm Daughters. Certification of GoodHemp varieties further strengthens its portfolio, while the company is well-funded for future growth. Increased operating expenses were noted, primarily due to R&D and employee-related costs.
Arcadia Biosciences (Nasdaq: RKDA) will release its 2020 fourth-quarter and annual financial results on March 30, 2021, after market close. A conference call is scheduled for 4:30 p.m. ET to discuss these results and the year's strategic achievements. Interested parties can join via U.S. toll-free dial-in or international numbers. The call will be accessible via a live webcast on the company's investor website, with a replay available afterward.
Arcadia focuses on enhancing crop quality and nutrition, with its GoodWheat and GoodHemp brands delivering innovative solutions in the agricultural market.
FAQ
What is the current stock price of Arcadia Biosciences (RKDA)?
What is the market cap of Arcadia Biosciences (RKDA)?
What does Arcadia Biosciences, Inc. specialize in?
What are some of Arcadia’s notable product brands?
How does Arcadia Biosciences contribute to agricultural sustainability?
What crops does Arcadia Biosciences focus on?
How does Arcadia Biosciences enhance the value of crops?
Where can I find more information about Arcadia Biosciences?
What recent achievements has Arcadia Biosciences made?
How does Arcadia Biosciences help consumer packaged goods companies?
What is the mission of Arcadia Biosciences?
What sectors does Arcadia Biosciences operate in?
